Careers  |  Sign In  |  Register  |   Twitter

Inhaled Insulin Proves Effective

Bloomberg News reports that MannKind’s inhaled insulin product, Afrezza, “was more effective at controlling diabetics’ blood sugar levels when combined with oral diabetes medicines compared to those drugs alone.” Afrezza is “a powdered form of insulin delivered through an inhaler,” that the California-based company has been trying to bring to market for the past six years. The most recent results of the product’s benefits “are from the last stage of testing required to get U.S. regulatory approval. If cleared for sale, the product would be the only inhaled insulin on the market, potentially replacing injections and pumps.”

Read the article published by Bloomberg News.